Latest Share Chat

Tissue Regenix Appoints Consort Medical CEO As Non-Executive Director

Tue, 19th Jan 2016 08:52

LONDON (Alliance News) - Regenerative medical devices company Tissue Regenix Group PLC on Tuesday said it has appointed the chief executive of Consort Medical PLC as a non-executive director.

Jonathan Glenn has been the CEO at Consort, an AIM-listed contract development and manufacturing company for the pharmaceutical industry, since 2007.

Shares in Tissue Regenix were up 1.1% to 13.40 pence.

By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance

Related Shares

More News

18 Apr 2024 14:12

UK shareholder meetings calendar - next 7 days

19 Mar 2024 14:24

Tissue Regenix annual loss narrows sharply as revenue jumps

(Alliance News) - Tissue Regenix Group PLC on Tuesday said it was aiming for longer-term growth as it reported a sharp reduction in its annual losses.

12 Mar 2024 14:29

UK earnings, trading statements calendar - next 7 days

6 Feb 2024 10:42

IN BRIEF: Tissue Regenix ships first allograft products order

Tissue Regenix Group PLC - Leeds, England-based medical devices - First order of its allograft products has been shipped from its third-party Irish lo...

25 Jan 2024 20:21

TRADING UPDATES: Treatt revenue falls; Secure Trust profit picks up

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: